Tecik, M. And Adan, A. 2024. Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors. Current Treatment Options in Oncology , vol.25, no.6 , 719-751.

Tecik, M., & Adan, A., (2024). Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors. Current Treatment Options in Oncology , vol.25, no.6, 719-751.

Tecik, Melisa, And AYSUN ADAN. "Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors," Current Treatment Options in Oncology , vol.25, no.6, 719-751, 2024

Tecik, Melisa And Adan, AYSUN. "Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors." Current Treatment Options in Oncology , vol.25, no.6, pp.719-751, 2024

Tecik, M. And Adan, A. (2024) . "Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors." Current Treatment Options in Oncology , vol.25, no.6, pp.719-751.

@article{article, author={Melisa Tecik And author={AYSUN ADAN}, title={Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors}, journal={Current Treatment Options in Oncology}, year=2024, pages={719-751} }